Jared Weaver, Southern Utah University
Physical Sciences
Organoarsenic are compounds containing carbon and arsenic. These compounds have been shown to have biological activity and pharmaceutical properties, and some organoarsenic compounds have even displayed potential for aiding in current medical problems up to and including possibilities as anticancer agents. Currently relatively little research is being done on organoarsenic compounds by the pharmaceutical community due to current views from the media based largely upon the toxicity of their inorganic arsenic counterparts (inorganic compounds are compounds not containing carbon), organoarsenic compounds however have significantly toxicity. Also, like with any medicine, toxicity depends predominately upon concentration, and given a high enough concentration organoarsenic compounds would logically follow the same trend. Synthesis of a large variety of novel organoarsenic compounds has been found via a reaction involving a variety of aldehydes or ketones and 2-(Dichloroarsino)benzaminium chloride. Research will focus on synthesis, isolation, and characterization of a library of organoarsenic compounds and then determine their respective biological activities. Synthesis will determine mechanistic requirements of said reaction and will be done to produce a diverse selection of organoarsenic compounds. Compounds will be isolated through precipitation of product and vacuum filtration of formed product. Structure will be determined through IR, NMR, and Gas Chromatography/ Mass Spectrometry, and through X-ray crystallography. Biological activity is suspected with potential for testing via a Kirby-Bauer Disc treatment. It is hypothesized that novel organoarsenic products will be formed by reaction of 2-(Dichloroarsino)benzaminium chloride with all carbonyl compounds containing an alpha carbon with at least one proton used, and that compounds synthesized will inhibit bacterial growth.